Abstract
Ondansetron is a widely used anti-emetic for managing nausea and vomiting caused by chemotherapy, gastroenteritis, motion sickness, and morning sickness. Traditional formulations include dispersible tablets, syrups, and injections, but these can be challenging for pediatric patients due to the bitter taste of ondansetron. To enhance palatability and patient compliance, we propose the development of a novel dosage form: ondansetron-infused chocolate. This innovative approach leverages chocolate’s natural appeal to pediatric patients, effectively masking the drug’s bitterness. By utilizing a chocolate base, we aim to improve the acceptability of ondansetron, thereby ensuring better adherence to treatment regimens. This chocolate drug delivery system represents a versatile and child-friendly technology, potentially transforming how pediatric anti-emetic therapy is administered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmaceutical Sciences and Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
